Marketing an addiction treatment center or a rehab center is not like marketing most businesses. You are advertising care for a vulnerable population seeking treatment options, handling protected health information, and operating in a field with its own federal laws and platform rules. Get it right and your growth is durable. Get it wrong and a single misstep can mean regulatory penalties, lost ad accounts, and damaged trust in an industry where trust is the entire product.

This guide explains the main compliance areas that shape rehab marketing: HIPAA and data protection, the rules around online tracking, the FTC's expanding reach, EKRA and patient brokering, and LegitScript certification for paid ads. It is written to help marketing and admissions leaders understand the landscape and ask better questions. It is readiness guidance, not legal advice, and it should sit alongside, never replace, your attorney or compliance officer.

Why behavioral health is different

A treatment center's marketing stack touches sensitive data at almost every step. Intake forms collect personal and health details. Call recordings and transcripts capture conversations about a person's condition. Tracking pixels and analytics record behavior on pages about specific conditions. CRMs store the whole journey. Each of these is a place where protected health information (PHI) can leak, and where a lapse becomes a reportable event rather than a minor bug.

Because of that, compliance in rehab marketing is not a checkbox at the end. It is a design constraint from the start. The goal is ethical marketing that grows admissions without ever creating exposure. Treatment providers must build trust with patients by maintaining ethical standards across all marketing activities. This also supports better treatment outcomes.

HIPAA and online tracking

HIPAA governs how covered entities and their business associates handle PHI. For marketing, the friction point in recent years has been online tracking technologies: pixels, tags, and analytics scripts that can transmit identifiable information to third parties such as advertising platforms.

The HHS Office for Civil Rights (OCR) issued a bulletin on tracking technologies in December 2022 and updated it in March 2024, warning that sending PHI to third parties through these tools could violate HIPAA. In June 2024, a federal court in Texas vacated part of that guidance, specifically the portion treating an IP address plus a visit to an unauthenticated public health page as automatically triggering HIPAA. That ruling narrowed the guidance, but it did not remove the underlying obligation to protect PHI. The safe posture has not changed: be deliberate about what tracking you deploy, what it collects, and where that data goes.

Practical steps:

  • Inventory every pixel, tag, and analytics tool on your site and know what each one transmits.
  • Use vendors that will sign a Business Associate Agreement (BAA) where PHI may be involved. Note that some mainstream tools, such as standard Google Analytics, generally do not sign BAAs.
  • Limit and review call recording and transcription, and decide carefully what, if anything, is passed to ad platforms.

We say "HIPAA-aligned" rather than asserting any tool is "HIPAA-compliant," because compliance depends on how the entire system is configured and operated, not on any single product's label.

The FTC is now a major player

Even where HIPAA does not strictly apply, the Federal Trade Commission has moved aggressively on health data privacy. Two enforcement actions made the stakes clear: GoodRx agreed to a 1.5 million dollar civil penalty in 2023 for sharing personal health information with platforms like Facebook and Google without proper consent, and BetterHelp agreed to a 7.8 million dollar settlement over sharing consumers' sensitive data with advertisers.

The FTC also updated its Health Breach Notification Rule, with changes taking effect on July 29, 2024, broadening the rule to cover many digital health tools and apps that are not subject to HIPAA. The lesson for treatment centers: even if a given tool sits outside HIPAA, sharing sensitive health data for advertising without clear consent can still draw federal enforcement. Healthcare marketing faces the same FTC scrutiny.

EKRA and patient brokering

The Eliminating Kickbacks in Recovery Act (EKRA), enacted in 2018 and codified at 18 U.S.C. 220, is the law most specific to addiction treatment marketing. It was passed to fight patient brokering, the practice of paying for patient referrals. EKRA broadly prohibits paying or receiving kickbacks for referrals to recovery homes, clinical treatment facilities, and laboratories, and it applies to all payors, including private insurance and cash-pay, not just federal programs.

Why marketers must care: EKRA has reached marketing arrangements directly. In United States v. Schena, a court found that paying marketers illegal kickbacks to induce patient referrals was unlawful, and held it irrelevant whether marketers recruited patients directly or through physicians. Penalties are severe, up to 20 years in prison and a 200,000 dollar fine per violation, and enforcement activity has been increasing.

The practical implication is in how you structure marketing and lead-generation relationships. Compensation tied to the volume or value of referrals, or per-admission payments to marketers, is a classic risk area. Structure agreements with EKRA in mind, document all referral sources, and get them reviewed by counsel.

LegitScript certification for paid ads

If you want to run paid search or social ads for an addiction treatment program, you generally need LegitScript certification. In 2018 Google Ads began requiring it for addiction treatment advertisers, and Meta and Microsoft adopted similar requirements. Without certification, plus the separate account-level authorization Google requires, ads targeting addiction-related terms will not serve.

The certification itself is a compliance exercise: LegitScript reviews licensing, disclosure of legal or regulatory history, clinical staff qualifications, website accuracy, privacy practices, and honest advertising. It exists precisely because patient-brokering schemes between roughly 2015 and 2019 caused real harm and federal prosecutions. Budget for the certification, and treat it as a recurring requirement rather than a one-time hurdle.

Common compliance mistakes

  • Bolting tracking on without review. Adding a pixel or analytics tool "because everyone uses it" is the fastest route to a PHI disclosure problem.
  • Assuming a tool is compliant by default. No tool is compliant on its own. Compliance comes from configuration, BAAs, and process.
  • Structuring marketing pay around referrals. Per-referral or per-admission marketer compensation is an EKRA risk. Have arrangements reviewed.
  • Skipping LegitScript and wondering why ads will not run. Certification and account authorization are prerequisites, not optional polish.
  • Treating compliance as a one-time audit. Rules, platforms, and your own stack change. Readiness is continuous: assess, remediate, monitor.

Addiction marketing demands this level of vigilance.

Building a readiness program

In the addiction treatment market, digital marketing strategies and the work of specialized marketing agencies must address patient acquisition, content marketing, and regulatory compliance across all marketing channels.

A workable approach is methodical rather than reactive: assess how PHI moves through your marketing and admissions stack, run a risk analysis across technical, physical, and administrative safeguards, fix the gaps with a clear remediation plan, follow best practices for data minimization, keep policies and vendor BAAs current, train staff who touch sensitive data, and monitor on an ongoing basis. Because your marketing and your data protection share the same tools, the two should be designed together rather than handed to separate vendors who never talk. Ethical rehab marketing also improves your conversion rate from inquiry to admission. Health marketing for behavioral health providers demands transparency at every step.

Prefer to have this handled with data-security specialists alongside your marketing? See our HIPAA-aligned marketing and data protection service for rehab centers, and see how compliance underpins your wider drug rehab SEO.

Manuel Muñoz
One client per area
Talk to our team about your growth

Book a free, no-pressure call with the specialists who would run your marketing. You get a clear plan and an honest quote, whether or not we work together.

Book a free call →

Frequently asked questions

Does HIPAA apply to my treatment center's website tracking? If your center is a HIPAA covered entity and tracking tools transmit PHI to third parties, HIPAA obligations can apply. A 2024 court ruling narrowed part of the OCR guidance, but the duty to protect PHI remains. Inventory your tracking and involve your compliance team.

What is EKRA and why does it affect marketing? EKRA is a federal law against paying or receiving kickbacks for patient referrals to treatment facilities, recovery homes, and labs. It applies to private payors too, and courts have applied it to marketing arrangements, so referral-based marketer pay is a significant risk area.

Do I need LegitScript certification to advertise a rehab? To run addiction treatment ads on Google, Meta, and Microsoft, yes, you generally need LegitScript certification, plus separate account authorization on Google. Ads on addiction-related terms will not serve without it.

Can I use Google Analytics on a treatment center website? It depends on configuration and what data is collected. Standard Google Analytics generally does not come with a Business Associate Agreement, so transmitting PHI through it is a risk. Review your setup with your compliance team before relying on it.

Is this legal advice? No. This is readiness and educational guidance. Compliance decisions should be made with your attorney or compliance officer, who can apply these rules to your specific situation.

Sources